Skip to main content

Global Negative Pressure Wound Therapy Market to Reach Value of USD 3.98 Billion by 2030 | Skyquest Technology

Global negative pressure wound therapy market is segmented on the basis of product, and type. Based on product, the market is segmented into conventional NPWT, single-use NPWT. In terms of type, the market is segmented into diabetic foot ulcers, venous leg ulcers, pressure ulcers, burn wounds, others. – Industry forecast 2023-2030

Westford USA, Jan. 16, 2024 (GLOBE NEWSWIRE) — According to SkyQuest report, the growth of the global negative pressure wound therapy market is primarily propelled by a range of compelling factors, with a prominent one being the increasing prevalence of chronic wounds. Conditions such as diabetic foot ulcers and venous leg ulcers have become increasingly common, necessitating advanced wound care management solutions. Negative pressure wound therapy has emerged as a critical and highly effective approach in addressing these complex wound cases.

Browse in-depth TOC on the “Negative Pressure Wound Therapy Market”

  • Pages – 157
  • Tables –  64
  • Figures – 75

The increasing demand for advanced wound care solutions is anticipated to drive the growth of the global negative pressure wound therapy market. Single-use NPWT devices are gaining remarkable traction, surpassing conventional products in wound care management within this evolving landscape.

Report Scope & Segmentation:                               

Attributes Details
Market Size in 2022 USD 2.35 Billion
2030 Value Projection USD 3.98 Billion
CAGR 6.8%
Forecast Period 2023-2030
Segments Covered
  • Product
  • Type
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Prominent Players in Global Negative Pressure Wound Therapy Market

  • Smith & Nephew plc
  • Mölnlycke Health Care AB
  • ConvaTec Group plc
  • Cardinal Health, Inc.
  • Talley Group Limited
  • Medela AG
  • Paul Hartmann AG
  • Acelity L.P. Inc.
  • Lohmann & Rauscher International GmbH & Co. KG
  • 3M Company
  • Medline Industries, Inc.
  • Coloplast A/S
  • Zimmer Biomet Holdings, Inc.
  • Genadyne Biotechnologies, Inc.
  • DeRoyal Industries, Inc.
  • Mölnlycke Health Care AB
  • Talley Group Limited
  • Medela AG
  • Cardinal Health, Inc.
  • ConvaTec Group plc

Get a sample copy of this report:

https://www.skyquestt.com/sample-request/negative-pressure-wound-therapy-market

Single-Use Devices Segment to Rise Significantly due to Versatile Use in Homecare Settings

Single-use negative pressure wound therapy (NPWT) devices segment is expected to undergo substantial growth, driven by several key factors. These devices are gaining traction due to their versatile use in homecare settings, where cost-effectiveness and convenience are paramount in the global negative pressure wound therapy market.

The market in North America solidified its position as the leading region in the global negative pressure wound therapy market, and this dominance can be attributed to a convergence of several compelling factors. Foremost among these is a well-established and sophisticated healthcare infrastructure that fosters innovation and accessibility to advanced medical technologies.

Browse summary of the report and Complete Table of Contents (ToC):

https://www.skyquestt.com/report/negative-pressure-wound-therapy-market

Pressure Ulcer Segment is Expected to Dominate Market due to Extended Treatment Duration

In 2022, the pressure ulcer segment firmly established itself as the dominant force within the global negative pressure wound therapy market, commanding a substantial revenue share of 31.3%. This prominence can be attributed to the extended treatment duration typically associated with pressure ulcers.

Regional market in Asia Pacific is poised to experience the most rapid expansion in the global negative pressure wound therapy market throughout the forecast period. This remarkable growth can be attributed to a confluence of regional factors. First and foremost, Asia Pacific’s steadily increasing geriatric population underscores the heightened demand for advanced wound care solutions, as elderly individuals are more susceptible to chronic wounds.

A comprehensive analysis of major global negative pressure wound therapy market players has been conducted recently. The report encompasses various aspects of the market, including collaborations, mergers, innovative business policies, and strategies, providing valuable insights into key trends and breakthroughs in the market. Furthermore, the report scrutinizes the market share of the top segments and presents a detailed geographic analysis. Lastly, the report highlights the major players in the industry and their endeavors to develop innovative solutions to cater to the growing demand.

Speak to Analyst for your custom requirements:

https://www.skyquestt.com/speak-with-analyst/negative-pressure-wound-therapy-market

Key Developments in Global Negative Pressure Wound Therapy Market

  • In 2022, Medela AG made a significant stride in wound care by introducing a cutting-edge generation of negative pressure wound therapy devices. These devices are equipped with advanced technologies designed to optimize and expedite wound healing, offering patients and healthcare providers more efficient and effective treatment options.
  • In 2022, Cardinal Health, Inc. executed a strategic move to bolster its position in the negative pressure wound therapy market. The company successfully acquired a prominent player within the industry, a move aimed at fortifying its product portfolio and expanding its market presence.

 Key Questions Answered in the Global Negative Pressure Wound Therapy Market Report

  • What specific growth drivers are projected to impact the market during the forecast period?
  • List the top companies in the market and explain how they have achieved their positions of influence.
  • In what ways do regional trends and patterns differ within the global market, and how these differences shape the market’s future growth?

Related Reports in SkyQuest’s Library:

Bionic Eye Market

Cold Plasma Market

Fill Finish Manufacturing Market

Hemoglobinopathies Treatment Market

CRISPR Technology Market

About Us:

SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally.

Address:

1 Apache Way, Westford, Massachusetts 01886

Phone:

USA (+1) 617-230-0741

Email: sales@skyquestt.com

LinkedIn Facebook Twitter

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.